CD4 and inflammatory bowel disease: Studies on IBD have revealed that CD4+αEβ7+ T cells from both healthy individuals and patients with UC exhibit decreased mRNA expression of regulatory T cell-related cytokines and surface molecules (such as Foxp3, IL-10, CTLA-4, and ICOS), when compared to CD4+αEβ7- T lymphocytes (40).